#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Pancreatic carcinoma Adrenoleukodystrophy Pericarditis Mucopolysaccharidosis I Oesophageal atresia Malignant fibrous histiocytoma Cystic fibrosis gastrointestinal disease Myxofibrosarcoma Cutaneous T-cell lymphoma stage II ROHHAD syndrome Non-Hodgkin's lymphoma unspecified histology indolent Aspergillus infection Primary adrenal insufficiency Diabetes insipidus Neonatal alloimmune thrombocytopenia More trials…
Learn about Rare Diseases

Vascular malformation – Basic Information Breast angiosarcoma – Basic Information Richter’s syndrome – Trials in Disease Myelodysplastic syndrome – Trials in Disease Rosai-Dorfman syndrome – Trials in Disease Mucopolysaccharidosis III – Treatment Lennox-Gastaut syndrome – Diagnostics Glomerulonephritis membranoproliferative – Treatment Leukoencephalopathy – Diagnostics Castleman’s disease – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

GSKVX000000070250 GSKVX000000034797 Selgantolimod Cobolimab Azd8205 Cibotercept Leuprorelin Acetate Ivabradine Pamapimod Avalglucosidase Alfa Rugonersen Favezelimab Ezetimibe Aflibercept SOVATELTIDE FG001 Rtx001 Abrocitinib Ramucirumab FOSMANOGEPIX More therapies…

Learn about Your Condition

Haemodynamic instability Niemann-Pick disease Thrombosis prophylaxis Venous thrombosis Uveal melanoma Neurodevelopmental disorder Postoperative delirium Spinal cord injury Bone metabolism disorder Adenocarcinoma Paresis Caesarean section Ventricular tachycardia Head and neck cancer stage IV Thromboembolectomy More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Extranodal marginal zone B-cell lymphoma (MALT type)

Epcoritamab for Adults with Relapsed or Refractory Marginal Zone Lymphoma: A Phase II Open‑Label Study

Not yet recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Epcoritamab
Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Obinutuzumab
Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Copanlisib Dihydrochloride
- Rituximab
Study on Chlorambucil and Rituximab for Patients with MALT Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Extranodal marginal zone B-cell lymphoma (MALT type)
Investigated Drugs:
- Chlorambucil
- Rituximab

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Extranodal marginal zone B-cell lymphoma (MALT type)

Epcoritamab for Adults with Relapsed or Refractory Marginal Zone Lymphoma: A Phase II Open‑Label Study

Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

Study on Chlorambucil and Rituximab for Patients with MALT Lymphoma

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies